Real world outcomes of RRMM using Kyprolis | Sharlene Dong, MD, MS | EHA 2024
Vložit
- čas přidán 27. 07. 2024
- Sharlene Dong presents on the outcomes of relapsed and refractory multiple myeloma patients using carfilzomib.
The HealthTree Foundation for Multiple Myeloma brings information from the experts to the patients! Learn more at www.healthtree.org/myeloma/co...
Donate to the HealthTree Foundation for Multiple Myeloma or learn more about additional myeloma support we offer here: give.healthtree.org/campaign/...
HealthTree Cure Hub helps you find your best treatment options and accelerate a cure for multiple myeloma. Join today at www.healthtree.org/
Follow HealthTree:
healthtreeformm
healthtreeformultiplemyeloma
instragram.com/healthtreeformultiplemyeloma - Věda a technologie
